Microneedle Delivery of Beta-Cells Avoids Host Immune Rejection
|
By LabMedica International staff writers Posted on 28 Mar 2016 |
|
Image: A scanning electron microscopic (SEM) image of the microneedle-array beta-cell patch (Photo courtesy of Dr. Zhen Gu, University of North Carolina).
A novel skin patch filled with living insulin-secreting beta cells was shown to regulate glucose levels in a mouse diabetes model for up to 10 hours while avoiding adverse immune responses.
Attempts to treat diabetes by transplanting beta-cells have not been particularly successful, since most transplants are rejected and the medications used to suppress the immune system interfere with the activity of beta cells and insulin.
Investigators at the University of North Carolina (Chapel Hill, USA) and North Carolina State University (Raleigh, USA) devised a way to protect foreign beta cells from attack by the immune system.
They described in the March 1, 2016, online edition of the journal Advanced Materials an innovative microneedle (MN)-based cell therapy device that enabled glucose-responsive regulation of the insulin secretion from exogenous pancreatic beta-cells without implantation.
The device was a synthetic patch comprising hundreds of biocompatible microneedles, each packed with thousands of alginate encapsulated beta-cells and culture media. When applied to the skin, the microneedles pierced capillaries and dermal blood vessels, forming a connection between the internal environment and the external cells of the patch that enabled diffusion of insulin from the patch into the skin.
Results revealed that one microneedle patch quickly reduced the blood-sugar levels (BGLs) of chemically induced type-1 diabetic mice and stabilized BGLs at a reduced level for over 10 hours. Repeated administration of the patch did not result in excess doses of insulin and did not induce hypoglycemia. Rather, application of a second patch extended the life of the treatment to 20 hours.
“This study provides a potential solution for the tough problem of rejection, which has long plagued studies on pancreatic cell transplants for diabetes,” said senior author Dr. Zhen Gu, assistant professor of biomedical engineering at the University of North Carolina. “Plus, it demonstrates that we can build a bridge between the physiological signals within the body and these therapeutic cells outside the body to keep glucose levels under control.”
Related Links:
University of North Carolina
North Carolina State University
Attempts to treat diabetes by transplanting beta-cells have not been particularly successful, since most transplants are rejected and the medications used to suppress the immune system interfere with the activity of beta cells and insulin.
Investigators at the University of North Carolina (Chapel Hill, USA) and North Carolina State University (Raleigh, USA) devised a way to protect foreign beta cells from attack by the immune system.
They described in the March 1, 2016, online edition of the journal Advanced Materials an innovative microneedle (MN)-based cell therapy device that enabled glucose-responsive regulation of the insulin secretion from exogenous pancreatic beta-cells without implantation.
The device was a synthetic patch comprising hundreds of biocompatible microneedles, each packed with thousands of alginate encapsulated beta-cells and culture media. When applied to the skin, the microneedles pierced capillaries and dermal blood vessels, forming a connection between the internal environment and the external cells of the patch that enabled diffusion of insulin from the patch into the skin.
Results revealed that one microneedle patch quickly reduced the blood-sugar levels (BGLs) of chemically induced type-1 diabetic mice and stabilized BGLs at a reduced level for over 10 hours. Repeated administration of the patch did not result in excess doses of insulin and did not induce hypoglycemia. Rather, application of a second patch extended the life of the treatment to 20 hours.
“This study provides a potential solution for the tough problem of rejection, which has long plagued studies on pancreatic cell transplants for diabetes,” said senior author Dr. Zhen Gu, assistant professor of biomedical engineering at the University of North Carolina. “Plus, it demonstrates that we can build a bridge between the physiological signals within the body and these therapeutic cells outside the body to keep glucose levels under control.”
Related Links:
University of North Carolina
North Carolina State University
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Blood Glucose Test Strip
AutoSense Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read more
Molecular Diagnostics
view channel
Fast Low-Cost Alzheimer’s Tests Could Detect Disease in Early and Silent Stages
Early diagnosis remains one of the greatest challenges in combating Alzheimer’s disease, the most common cause of age-related dementia. With symptoms like memory loss and confusion typically appearing... Read more
Further Investigation of FISH-Negative Tests for Renal Cell Carcinoma Improves Diagnostic Accuracy
Accurate diagnosis of renal cell carcinoma (RCC) is critical to determining the right therapy, but standard diagnostic methods can sometimes miss important genetic alterations. Now, researchers have discovered... Read more
First Direct Measurement of Dementia-Linked Proteins to Enable Early Alzheimer’s Detection
The disease process in Alzheimer’s begins long before memory loss or cognitive decline becomes apparent. During this silent phase, misfolded proteins gradually form amyloid fibrils, which accumulate in... Read more
Hematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Immunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read more
Microbiology
view channel
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
Candida bloodstream infections are a growing global health threat, causing an estimated 6 million cases and 3.8 million deaths annually. Hospitals are particularly vulnerable, as weakened patients after... Read more
Pathology
view channel
3D Genome Mapping Tool to Improve Diagnosis and Treatment of Genetic Diseases
Standard laboratory tests often fail to detect complex DNA rearrangements that underlie many genetic diseases. To bridge this diagnostic gap, researchers have developed a 3D chromosome mapping method that... Read more
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read more
Technology
view channel
Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
Early diagnosis of psychiatric disorders such as depression, schizophrenia, and bipolar disorder remains one of medicine’s most pressing challenges. Current diagnostic methods rely heavily on clinical... Read more
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read more
Industry
view channel
Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
QIAGEN (Venlo, Netherlands) has entered into a definitive agreement to fully acquire Parse Biosciences (Seattle, WA, USA), a provider of scalable, instrument-free solutions for single-cell research.... Read more
Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15.... Read more
Advanced Instruments Merged Under Nova Biomedical Name
Advanced Instruments (Norwood, MA, USA) and Nova Biomedical (Waltham, MA, USA) are now officially doing business under a single, unified brand. This transformation is expected to deliver greater value... Read more
